ClassID:

109056

C12N15/115 - CPC Classification

Classification description:

Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers

Recent Application in this class:
#1
20260146998
2026-05-28

Bio-Ink and Its Preparation and Application

#2
20260144899
2026-05-28

CIRCULAR RNAS FOR CELLULAR THERAPY

#3
20260118351
2026-04-30

System and Method for Identifying the Presence of Insects

#4
20260117282
2026-04-30

High Throughput Cell-Based Screening For Aptamers

#5
20260109989
2026-04-23

COMPOSITIONS AND METHODS FOR THE SYNTHESIS AND IDENTIFICATION OF COVALENT APTAMERS

#6
20260104411
2026-04-16

HIGH-AFFINITY NUCLEIC ACID APTAMER FOR HISTAMINE AND AQUATIC PRODUCT FRESHNESS ENZYME SENSOR

#7
20260098270
2026-04-09

MULTIVALENT TRIDENT APTAMERS FOR MOLECULAR RECOGNITION, METHODS OF MAKING AND USES THEREOF

#8
20260092283
2026-04-02

COMPOSITIONS AND METHODS FOR THE TREATMENT OF COMPLICATIONS AND DISORDERS RELATING TO VON WILLEBRAND FACTOR

#9
20260092101
2026-04-02

METHOD FOR TREATING SEPSIS AND RELATED DISEASES

#10
20260078382
2026-03-19

G-QUADRUPLEX-CONTAINING OLIGONUCLEOTIDES

#11
20260077053
2026-03-19

ANTIBODIES AND ENONOMERS

#12
20260071989
2026-03-12

SINGLE-STRANDED DNA MOLECULAR RECOGNITION ELEMENTS AGAINST CYANOTOXIN L-BMAA

#13
20260071209
2026-03-12

Method for Screening and Rationally Engineering Riboswitch Capable of Specifically Recognizing Doxycycline

#14
20260062705
2026-03-05

TREATMENT FOR OVARIAN CANCER WITH OLIGONUCLEOTIDES TARGETING FIBROBLAST ACTIVATION PROTEIN ALPHA

#15
20260062453
2026-03-05

DEGRADATION TARGETING AGENTS AND USES THEREOF

#16
20260056202
2026-02-26

USE OF MODIFIED PHAGE FOR CAPTURING AND SUBTYPING OF CANCER CELLS

#17
20260055416
2026-02-26

CLICK CHEMISTRY LIGAND

#18
20260049321
2026-02-19

METHODS AND COMPOSITIONS OF APTAMERS FOR DETECTION OF LOW COMPLEXITY MOLECULES

#19
20260042828
2026-02-12

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS

#20
20260035704
2026-02-05

COMPOSITIONS AND METHODS INVOLVING APTAMER SWITCH POLYNUCLEOTIDES

#21
20260034213
2026-02-05

SYSTEMS AND METHODS FOR TARGETING NAD-BASED PATHWAYS FOR TREATMENT OF CANCER

#22
20260034156
2026-02-05

INHIBITORS OF SARM1 IN COMBINATION WITH NAD+ OR A NAD+ PRECURSOR

#23
20260022385
2026-01-22

DNA APTAMERS THAT BIND TO ALGINATE GELS

#24
20260015627
2026-01-15

COMPOSITIONS AND METHODS FOR IMPROVED PROTEIN TRANSLATION FROM RECOMBINANT CIRCULAR RNAS

#25
20260015619
2026-01-15

METHODS FOR PREPARING APTAMERS FOR SMALL MOLECULES

#26
20260009038
2026-01-08

COMPOSITIONS AND METHODS RELATED TO NUCLEIC ACID SENSORS

#27
20260002935
2026-01-01

CHEMICAL SENSORS EMPLOYING pH-SENSITIVE APTAMERS

#28
20260002163
2026-01-01

COMPOSITIONS AND METHODS FOR TREATING PANCREATIC CANCER

#29
20250388953
2025-12-25

MULTIPLEXABLE APTAMER-BASED LIGAND DETECTION

#30
20250388931
2025-12-25

REGULATION OF GENE EXPRESSION BY APTAMER-MEDIATED MODULATION OF ALTERNATIVE SPLICING

#31
20250388908
2025-12-25

METAL HOMEOSTASIS REGULATION

#32
20250388907
2025-12-25

MULTISPECIFIC POLYNUCLEOTIDE NANOSTRUCTURES FOR CANCER DETECTION AND THERAPY

#33
20250388621
2025-12-25

RNA-DNA FUSOMERS AND METHODS OF USE THEREOF

#34
20250376675
2025-12-11

METHOD FOR SCREENING RNA APTAMER

#35
20250369001
2025-12-04

BUILDING DESIGNER RNA NANO-STRUCTURES FOR SYNTHETIC BIOLOGY APPLICATIONS

#36
20250369000
2025-12-04

THERMOSTABLE POLYMERASE INHIBITOR COMPOSITIONS AND METHODS

#37
20250361504
2025-11-27

SPATIAL MRNA/PROTEIN CO-ASSAYS USING APTAMERS

#38
20250354297
2025-11-20

SHIELDED SMALL NUCLEOTIDES FOR INTRACELLULAR BARCODING

#39
20250354164
2025-11-20

RNA-GUIDED GENOME RECOMBINEERING AT KILOBASE SCALE

#40
20250347705
2025-11-13

Epitope-Specific hCG Binding Aptamers and Applications Thereof

#41
20250346908
2025-11-13

FLUOROGENIC NUCLEOSIDES

#42
20250346907
2025-11-13

COMPOUNDS AND METHODS FOR REDUCING GLYCOGEN SYNTHASE 1

#43
20250340890
2025-11-06

DNA APTAMERS AS UNIVERSAL INHIBITORS OF SPIKE PROTEIN/HACE2 INTERACTIONS

#44
20250333814
2025-10-30

APTAMER-BASED MINERAL AND METAL COLLECTION

#45
20250333745
2025-10-30

METHODS AND COMPOSITIONS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE

#46
20250333696
2025-10-30

DNA-CHIMERIC ANTIGEN RECEPTOR T CELLS FOR IMMUNOTHERAPY

#47
20250332279
2025-10-30

PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING GLIOBLASTOMAS

#48
20250327082
2025-10-23

New C5a Binding Nucleic Acids

#49
20250327081
2025-10-23

TDP-43-BINDING SINGLE-STRANDED APTAMERS AND USES THEREOF

#50
20250325675
2025-10-23

APTAMER, CONJUGATE, COMPOSITION, METHOD FOR PREPARING SAME, AND USE THEREOF

#51
20250320507
2025-10-16

APPLICATION OF ZINC FINGER PROTEIN 217 GENE IN PREPARING MEDICINES FOR TREATING OSTEOPOROSIS

#52
20250320506
2025-10-16

ULTRASENSITIVE AND MULTIPLEXED CELL-FREE BIOSENSORS USING CASCADED AMPLIFICATION AND POSITIVE FEEDBACK

#53
20250313887
2025-10-09

SUPPRESSION OF TARGETED APTAMER CLUSTER

#54
20250313847
2025-10-09

APTAMER-BASED POLLUTANT PROTECTION

#55
20250313824
2025-10-09

FUNCTIONALIZED NUCLEIC ACID CONDENSATES AND RELATED CONDENSATE MONOMERS, LAYERED STRUCTURES, COMPOSITIONS METHODS AND SYSTEMS FOR SEPARATION, PURIFICATION, AND/OR DETECTION OF A BIOMOLECULAR TARGET

#56
20250304975
2025-10-02

APTAMER AND RIBOZYME EQUILIBRIUM SHIFTING (ARES) RNA CIRCUITS AND USES THEREOF

#57
20250304973
2025-10-02

HIGH-AFFINITY THROMBIN APTAMERS AND METHODS OF USE

#58
20250304972
2025-10-02

COMPOUNDS FOR INHIBITING THE INTERACTION OF SARS-COV2 WITH HUMAN PROTEIN ACE2

#59
20250304951
2025-10-02

DNA APTAMERS FOR INHIBITING REVERSE TRANSCRIPTASES

#60
20250304639
2025-10-02

TETRAHEDRAL FRAMEWORK NUCLEIC ACID MODIFIED BY APTAMER AND TRANSFORMING GROWTH FACTOR beta 3, AND PREPARATION METHOD THEREOF

#61
20250298026
2025-09-25

DNA Aptamers for Detection of L-Lactate and Methods Therefor

#62
20250297264
2025-09-25

RNA APTAMER TARGETING OF ADAM8 IN CANCER GROWTH AND METASTASIS

#63
20250283878
2025-09-11

NUCLEIC ACID APTAMER TEST STRIP, PREPARATION METHOD THEREFOR, AND USE THEREOF

#64
20250283150
2025-09-11

NUCLEIC ACID STRUCTURE

#65
20250283095
2025-09-11

Biradial Spherical Nucleic Acids

#66
20250283094
2025-09-11

Modified Nucleosides

#67
20250281621
2025-09-11

GPC3 APTAMERS AND VARIANTS AND USE THEREOF

#68
20250281598
2025-09-11

DNA DISPLAY OF FOLDED RNA LIBRARIES ENABLING RNA-SELEX WITHOUT REVERSE TRANSCRIPTION

#69
20250279163
2025-09-04

METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR APTAMER SELECTION

#70
20250277800
2025-09-04

NUCLEIC ACID SEQUENCES RESPONSIVE TO CREATININE IN CLINICALLY USEFUL RANGES

#71
20250270566
2025-08-28

DUAL-SPECIFICITY RNA ATPAMERS FOR REGULATING O-GLCNACYLATION

#72
20250269040
2025-08-28

CONJUGATE, PHARMACEUTICAL COMPOSITION COMPRISING SAME, METHOD FOR PREPARING SAME, AND USE THEREOF

#73
20250264473
2025-08-21

AFFINITY REAGENT, MARKER AND METHOD FOR ANALYSING A BIOLOGICAL SAMPLE

#74
20250263729
2025-08-21

NUCLEIC ACID APTAMER, COMPOSITION, USE OF APTAMER, DIAGNOSTIC KIT, METHOD FOR DETECTING OR DIAGNOSING TUMOURS AND CANCER TREATMENT METHOD

#75
20250262350
2025-08-21

MATRIX BOUND NANOVESICLES AND THEIR USE

#76
20250251394
2025-08-07

APTAMER-BASED ELECTROCHEMICAL DRUG DETECTION ASSAY

#77
20250243495
2025-07-31

Anti-Fibrinogen Aptamers

#78
20250243494
2025-07-31

APTAMER BASED AFFINITY CAPTURE METHODS FOR THE SELECTIVE ENRICHMENT OF HUMAN IMMUNOGLOBULIN FC DOMAINS

#79
20250235519
2025-07-24

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREATIC CANCER AND OTHER CANCERS

#80
20250230484
2025-07-17

USE OF APTAMERS IN PROTEOMICS

#81
20250230432
2025-07-17

METHODS AND COMPOSITIONS FOR THE MAKING AND USING OF GUIDE NUCLEIC ACIDS

#82
20250228883
2025-07-17

Process to Inhibit or Eliminate Eosinophilic Diseases of the Airway and Related Conditions

#83
20250223646
2025-07-10

METHODS FOR DETECTING AND TREATING CEREBRAL CAVERNOUS MALFORMATION

#84
20250223600
2025-07-10

INSULIN RECEPTOR-BINDING APTAMER DIMER AND USE THEREOF

#85
20250223592
2025-07-10

COMPOSITIONS AND METHODS FOR CIRCULAR RNA AFFINITY PURIFICATION

#86
20250223577
2025-07-10

HYBRID CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF

#87
20250223335
2025-07-10

PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST HEAD AND NECK SQUAMOUS CELL CARCINOMA AND OTHER CANCERS

#88
20250215515
2025-07-03

ANALYTES' DETECTION USING REGULATED IN VITRO TRANSCRIPTION

#89
20250215386
2025-07-03

TARGETED CELL SELECTION AND RELEASE USING APTAMER COMPLEXES IN A CELL PROCESSING SYSTEM

#90
20250208044
2025-06-26

SENSOR DEVICE FOR SENSING A PRESENCE OF AN ANALYTE IN A BIOLOGICAL MATERIAL

#91
20250207140
2025-06-26

RESPIRATORY TRACT INFECTION THERAPEUTICS AGAINST COVID-19

#92
20250205346
2025-06-26

ANTI-C5 AGENT FOR TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION (AMD) OR GEOGRAPHIC ATROPHY SECONDARY TO DRY AMD

#93
20250197868
2025-06-19

COMPOSITIONS AND METHODS FOR INHIBITING FACTOR D

#94
20250179444
2025-06-05

INHIBITION OF DNA POLYMERASES BY URACIL-DNA GLYCOSYLASE-CLEAVABLE OLIGONUCLEOTIDE LIGANDS

#95
20250179212
2025-06-05

METHODS OF TREATING CANCER AND MONITORING CANCER PROGRESSION

#96
20250177573
2025-06-05

Materials & Methods for Treatment of Macular Degeneration

#97
20250171787
2025-05-29

APTAMERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR PREVENTING OR TREATING BCMA-ASSOCIATED DISEASES OR CONDITIONS

#98
20250154459
2025-05-15

PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST RENAL CELL CARCINOMA (RCC) AND OTHER CANCERS

#99
20250147052
2025-05-08

Aptamers for Cortisol and Other Hormone Sensing, Aptamer-Based Sensors, and a Method for Optimizing Conformation-Switching Aptamers for Biosensing Applications

#100
20250145990
2025-05-08

TRANS-SPLICING RNA (TSRNA)

#101
20250145686
2025-05-08

UTERINE CANCER TREATMENTS

#102
20250144192
2025-05-08

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS

#103
20250137892
2025-05-01

METHODS, COMPOSITIONS, AND DEVICES INVOLVING PSEUDOKNOT FORMATION

#104
20250136997
2025-05-01

COMPOSITIONS FOR SEQUESTERING ISOAMYL AMINE AND METHODS OF USE THEREFOR

#105
20250130196
2025-04-24

Electrochemical Aptamer Sensors with Strong Sensor Response to Large Analytes

#106
20250129373
2025-04-24

Oligonucleotides Comprising Modified Nucleosides

#107
20250127917
2025-04-24

COMPOSITIONS AND METHODS FOR TREATING CANCERS

#108
20250122502
2025-04-17

Bifunctional Molecules and Methods of Using Thereof

#109
20250116035
2025-04-10

A METHOD FOR REPRODUCIBLE APTAMER SELECTION USING CLOSED SEQUENCE SOLUTION SPACES

#110
20250115952
2025-04-10

A METHOD FOR REPRODUCIBLE APTAMER SELECTION USED TO IDENTIFY APTAMERS THAT BIND TO UNKNOWN BIOMARKERS

#111
20250115919
2025-04-10

COMPOSITIONS AND METHODS RELATED TO APTAMER-BASED COLORIMETRIC ASSAYS

#112
20250108137
2025-04-03

APTAMERS SPECIFIC TO EBV-ASSOCIATED MALIGNANCIES AND THEIR APPLICATIONS IN CANCER IMAGING AND THERAPIES

#113
20250108111
2025-04-03

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

#114
20250101437
2025-03-27

APTAMERS FOR DETECTING VARIANTS OF A TARGET ANALYTE, METHODS OF MAKING AND USES THEREOF

#115
20250101436
2025-03-27

APTAMERS AND SMALL MOLECULE LIGANDS

#116
20250101435
2025-03-27

COMPOSITIONS AND METHODS TO TREAT CANCER

#117
20250101434
2025-03-27

Interferon Production Using Short RNA Duplexes

#118
20250093291
2025-03-20

NUCLEIC ACID PROBE, CHEMICAL SENSOR, AND DETECTION METHOD

#119
20250093266
2025-03-20

Aptamer-Based Fluorescence Polarization Detection Method for Extracellular Vesicles and Its Application

#120
20250092406
2025-03-20

FUNCTIONALLY-ENHANCED XNA

#121
20250084143
2025-03-13

ANTIGENIC PEPTIDES DERIVING FROM UROCORTIN 3 AND USES THEREOF FOR THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES

#122
20250082244
2025-03-13

WEARABLE APTAMER FIELD-EFFECT TRANSISTOR SENSING SYSTEM FOR NONINVASIVE CORTISOL MONITORING AND WEARABLE SYSTEM FOR STRESS SENSING

#123
20250074976
2025-03-06

PHARMACEUTICAL COMPOSITION FOR TREATING PERIPHERAL NERVE INJURY

#124
20250074961
2025-03-06

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST SMALL CELL LUNG CANCER AND OTHER CANCERS

#125
20250066796
2025-02-27

EXOGENOUS CONTROL OF MAMMALIAN GENE EXPRESSION THROUGH APTAMER-MEDIATED MODULATION OF POLYADENYLATION

#126
20250059548
2025-02-20

Aptamer Inactivation of Nucleases in Biological Solutions, Reagents, and Kits Used for Sample Collection, Nucleic Acid Testing, Isolation, and Genomic Characterization

#127
20250051857
2025-02-13

PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS

#128
20250049935
2025-02-13

BOTTLEBRUSH CONJUGATES FOR USE AS OLIGONUCLEOTIDE ENHANCERS

#129
20250043290
2025-02-06

RNA SEQUENCES THAT INDUCE FLUORESCENCE OF SMALL MOLECULE FLUOROPHORES, MOLECULAR COMPLEXES, SENSORS, AND METHODS OF USE THEREOF

#130
20250034594
2025-01-30

RNA-GUIDED GENOME RECOMBINEERING AT KILOBASE SCALE

#131
20250027090
2025-01-23

MIRROR-IMAGE SELECTION OF L-NUCLEIC ACID APTAMERS

#132
20250020645
2025-01-16

A4B1 BINDING APTAMERS

#133
20250001005
2025-01-02

BLOCK COPOLYMERS AND USES THEREOF

#134
20250000889
2025-01-02

METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS

#135
20240425903
2024-12-26

ENGINEERED GYRI-LIKE MUTEIN APTAMERS, AND RELATED METHODS

#136
20240425867
2024-12-26

NUCLEIC ACID-BASED ASSEMBLY AND USES THEREOF

#137
20240425558
2024-12-26

PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS

#138
20240417739
2024-12-19

COMPOSITIONS AND METHODS FOR TREATMENT OF BLEEDING DISORDERS

#139
20240409982
2024-12-12

METHOD FOR ANALYSING A BIOLOGICAL SAMPLE

#140
20240408200
2024-12-12

METHODS OF CELL CULTURE FOR ADOPTIVE CELL THERAPY

#141
20240408166
2024-12-12

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

#142
20240401063
2024-12-05

Aptamer for DKK1 and Use Thereof

#143
20240401062
2024-12-05

HEAVY METAL TOXICITY REMEDIATION

#144
20240400695
2024-12-05

METHODS FOR PROMOTING T CELLS RESPONSE

#145
20240398799
2024-12-05

COMPOSITIONS AND METHODS FOR GENERATING SYNTHETIC LETHALITY IN TUMORS

#146
20240392303
2024-11-28

RNA TARGETING OF MUTATIONS VIA SUPPRESSOR tRNAs AND DEAMINASES

#147
20240392302
2024-11-28

METHOD FOR DETECTING AND QUANTIFYING RNA

#148
20240384342
2024-11-21

MATERIALS AND METHODS FOR CONTROLLING GENE EXPRESSION

#149
20240384275
2024-11-21

C5a binding nucleic acids

#150
20240376480
2024-11-14

TREATMENT OF ELEVATED METABOLITE LEVELS USING NANOCARRIERS

#151
20240376479
2024-11-14

APTAMERS FOR TARGETED ACTIVATION OF T CELL-MEDIATED IMMUNITY

#152
20240374733
2024-11-14

PH-RESPONSIVE LIPID DERIVATIVE

#153
20240368655
2024-11-07

CLICK HANDLE-MODIFIED DEOXY-FLUOROARABINO NUCLEIC ACID AS A SYNTHETIC GENETIC POLYMER CAPABLE OF POST-POLYMERIZATION FUNCTIONALIZATION

#154
20240360458
2024-10-31

TARGETED AND SLOW-RELEASE DRUG CONJUGATE COMPOSITION

#155
20240353401
2024-10-24

Compositions and methods for detecting SARS-CoV-2 spike protein

#156
20240352467
2024-10-24

CHIMERIC COMPLEX AND THERAPEUTIC USES THEREOF

#157
20240352466
2024-10-24

APTAMER-siRNA FUSIONS

#158
20240352465
2024-10-24

RNA TARGETING OF MUTATIONS VIA SUPPRESSOR tRNAs AND DEAMINASES

#159
20240350602
2024-10-24

NOVEL PEPTIDES & COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML & OTHER CANCERS

#160
20240343786
2024-10-17

METHODS FOR TREATING SICKLE CELL DISEASE OR BETA THALASSEMIA USING A COMPLEMENT ALTERNATIVE PATHWAY INHIBITOR

#161
20240336926
2024-10-10

PHARMACEUTICAL COMPOSITION FOR TREATING TRIPLE NEGATIVE BREAST CANCER, CONTAINING NON-NATURAL NUCLEIC ACID LIGAND AS ACTIVE INGREDIENT

#162
20240336925
2024-10-10

Riboswitch modulated gene therapy for retinal diseases

#163
20240335505
2024-10-10

PRODUCTS AND METHODS FOR PROMOTING MYOGENESIS

#164
20240327848
2024-10-03

NON-NATURAL NUCLEIC ACID LIGAND, USES THEREOF, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT

#165
20240327847
2024-10-03

COMPOSITIONS AND METHODS FOR RNA AFFINITY

#166
20240318178
2024-09-26

VON WILLEBRAND FACTOR (VWF)-TARGETING AGENTS AND METHODS OF USING THE SAME

#167
20240309385
2024-09-19

COMPOSITIONS AND METHODS RELATED TO NUCLEIC ACID ANTICOAGULANTS AND ANTIDOTES

#168
20240309379
2024-09-19

CTLA-4 APTAMER CONJUGATES

#169
20240309117
2024-09-19

APTAMER-PEPTIDE CONJUGATES

#170
20240307534
2024-09-19

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

#171
20240301476
2024-09-12

ANALYSIS METHOD

#172
20240301431
2024-09-12

DEVELOPMENT AND APPLICATION OF POLYMER-COATED GOLD NANOPARTICLE-APTAMER NANOCONSTRUCT HAVING SENSITIVITY TO REACTIVE OXYGEN SPECIES

#173
20240294910
2024-09-05

NOVEL THERAPEUTIC AGENT FOR SEPTICEMIA, AND A METHOD FOR SCREENING FOR SAME

#174
20240294903
2024-09-05

RNA-APTAMER-SENSORS

#175
20240294643
2024-09-05

COMPOSITIONS AND METHODS FOR MODULATING CANCER IMMUNE FITNESS

#176
20240287527
2024-08-29

VIRAL PROTEIN SPECIFIC APTAMERS AND METHODS OF USE IN DIAGNOSTICS, THERAPEUTIC PURPOSES

#177
20240287502
2024-08-29

OLIGONUCLEOTIDE-TETHERED NUCLEOTIDES

#178
20240285738
2024-08-29

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CLL AND OTHER CANCERS

#179
20240277870
2024-08-22

IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY

#180
20240277853
2024-08-22

MEDIUM-MOLECULAR-WEIGHT COMPOUND CONJUGATE FOR IMPROVING PHARMACOKINETIC PROFILE OF MEDIUM-MOLECULAR-WEIGHT COMPOUND AND METHOD OF PRODUCING THE SAME

#181
20240263181
2024-08-08

AFFINITY REAGENT

#182
20240255495
2024-08-01

COVALENT APTAMERS

#183
20240255462
2024-08-01

ELECTROCHEMICAL, APTAMER-BASED POINT-OF-CARE CEREBROSPINAL FLUID DETECTION

#184
20240247276
2024-07-25

HOMOLOGOUS RECOMBINATION VIA TRANSCRIPTIONAL ACTIVATION

#185
20240247274
2024-07-25

FATTY ACID CONJUGATES OF NUCLEIC ACIDS

#186
20240247273
2024-07-25

THERAPEUTIC OLIGONUCLEOTIDES

#187
20240240191
2024-07-18

RNA APTAMERS SPECIFIC FOR A-SYNUCLEIN PROTEIN FIBER CONFORMERS

#188
20240240178
2024-07-18

SIRNA CONSTRUCTS FOR INHIBITING GENE EXPRESSION IN TARGETED CANCER CELLS

#189
20240240177
2024-07-18

MULTITARGETING RNA COMPOSITIONS

#190
20240229045
2024-07-11

Aptamer for specifically recognizing soluble ST2 protein and application of the same

#191
20240229033
2024-07-11

Compositions for Inhibiting Growth of Targeted Cells

#192
20240229032
2024-07-11

Multitargeting RNA Immunotherapy Compositions

#193
20240228582
2024-07-11

TM4SF19 INHIBITOR AND USES THEREOF

#194
20240226328
2024-07-11

MODULATION OF GENE EXPRESSION FOR DISEASE TREATMENT

#195
20240226307
2024-07-11

NON-IMMUNOGENIC POEGMA-APTAMER CONJUGATES

#196
20240218377
2024-07-04

BISPECIFIC APTAMER FOR TREATING CANCER

#197
20240218376
2024-07-04

APTAMER-TYPE MULTI-WARHEAD COVALENT DRUG

#198
20240218375
2024-07-04

DNA APTAMER SPECIFICALLY BINDING TO METHYLATED DNA FRAGMENT AND SELECTION METHOD AND USE THEREOF

#199
20240218374
2024-07-04

Nucleic Acid Compounds That Bind Coronavirus Proteins

#200
20240209378
2024-06-27

METHODS AND COMPOSITIONS FOR PROTEIN AND PEPTIDE SEQUENCING

#201
20240209375
2024-06-27

Aptamers For Personal Health Care Applications

#202
20240207406
2024-06-27

METHODS AND COMPOSITIONS COMPRISING MHC CLASS I PEPTIDES

#203
20240200081
2024-06-20

NUCLEIC ACID MOLECULE CONJUGATE HAVING PROLONGED IN VIVO HALF-LIFE

#204
20240191241
2024-06-13

APTAMERS FOR USE IN THE TREATMENT OF CORONAVIRIDAE INFECTIONS

#205
20240191240
2024-06-13

DEFINED MULTI-CONJUGATES OLIGONUCLEOTIDES

#206
20240191239
2024-06-13

REGULATION OF GENE EXPRESSION THROUGH APTAMER-MODULATED POLYADENYLATION

#207
20240191232
2024-06-13

COMPOUNDS AND METHODS FOR REDUCING PLN EXPRESSION

#208
20240182909
2024-06-06

Checkpoint Aptamers as Therapeutics for Cancer Treatment

#209
20240182908
2024-06-06

DEOXYRIBONUCLEOSIDE OR DEOXYRIBONUCLEOTIDE HAVING NOVEL ARTIFICIAL BASE APPLICABLE TO SCREENING FOR DNA APTAMER, AND NUCLEIC ACID CONTAINING THE SAME

#210
20240175037
2024-05-30

HOMOLOGOUS RECOMBINATION VIA TRANSCRIPTIONAL ACTIVATION

#211
20240167042
2024-05-23

DEVELOPMENT OF APTAMERS FOR NEUTRALIZING ANTIBODIES IN DEMYELINATING DISEASES

#212
20240167037
2024-05-23

CANCER THERAPY

#213
20240167019
2024-05-23

APTAMERS, CONTAINERS AND METHODS FOR CELL TRANSDUCTION

#214
20240166742
2024-05-23

MOLECULES THAT BIND TO AND STABILIZE TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 (TREM2)

#215
20240158800
2024-05-16

RIBOSWITCH MODULATED GENE THERAPY FOR RETINAL DISEASES

#216
20240158799
2024-05-16

APTAMERS THAT SELECTIVELY BIND TO A SARS-COV-2 VIRUS NUCLEOCAPSID PROTEIN

#217
20240150772
2024-05-09

Nucleolin-targeting aptamers and methods of using the same

#218
20240150756
2024-05-09

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF

#219
20240148874
2024-05-09

IMMUNOADJUVANT-BASED HYDROGEL COMPOSITION AND USE THEREOF

#220
20240141430
2024-05-02

ANTIDOTE-MEDIATED REVERSAL OF EXTRACELLULAR APTAMER STAINING

#221
20240141411
2024-05-02

MULTIPLEX RNA TARGETING

#222
20240140978
2024-05-02

THERAPEUTIC OLIGONUCLEOTIDES

#223
20240139328
2024-05-02

ANTI-C5 AGENT FOR TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION (AMD) OR GEOGRAPHIC ATROPHY SECONDARY TO DRY AMD

#224
20240132571
2024-04-25

TM4SF19 INHIBITOR AND USES THEREOF

#225
20240131188
2024-04-25

MODULATION OF GENE EXPRESSION FOR DISEASE TREATMENT

#226
20240131171
2024-04-25

NON-IMMUNOGENIC POEGMA-APTAMER CONJUGATES

#227
20240124932
2024-04-18

Hybridization Chain Reaction Methods for In Situ Molecular Detection

#228
20240124883
2024-04-18

DNA APTAMERS AND COMPOSITIONS TARGETING ALPHA-SYNUCLEIN AND METHODS OF MAKING AND USING SAME

#229
20240123044
2024-04-18

Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers

#230
20240110237
2024-04-04

FUNCTIONAL LIGANDS

#231
20240108757
2024-04-04

ENGINEERED EXTRACELLULAR VESICLES AND THEIR USES

#232
20240102023
2024-03-28

NOVEL RNA APTAMER INTERVENES ESTROGEN RECEPTOR INTERACTION WITH COACTIVATOR MED1 TO OVERCOME BREAST CANCER METASTASIS

#233
20240102022
2024-03-28

MODULATING BONE MORPHOGENIC PROTEIN (BMP) SIGNALING IN THE TREATMENT OF ALZHEIMER'S DISEASE

#234
20240102003
2024-03-28

OLIGONUCLEOTIDE-TETHERED NUCLEOTIDES

#235
20240100137
2024-03-28

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS

#236
20240093205
2024-03-21

DUAL CHECKPOINT INHIBITOR APTAMER BASED THERAPEUTICS

#237
20240093193
2024-03-21

DEAD GUIDES FOR CRISPR TRANSCRIPTION FACTORS

#238
20240083969
2024-03-14

IMMUNOTHERAPY WITH B*07 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS

#239
20240083947
2024-03-14

PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS

#240
20240082396
2024-03-14

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

#241
20240078661
2024-03-07

RNA MOLECULES, METHODS OF PRODUCING CIRCULAR RNA, AND TREATMENT METHODS

#242
20240076680
2024-03-07

APTAMERS AND USE OF THE APTAMERS IN THE DIAGNOSIS AND TREATMENT OF A SARS-COV-2 INFECTION

#243
20240060074
2024-02-22

DUAL-SPECIFIC APTAMER TRIGGERING CELL-MEDIATED CYTOTOXICITY TO LYSE HER2-POSITIVE CANCER CELLS

#244
20240060073
2024-02-22

DUAL-SPECIFIC APTAMER TRIGGERING CELL-MEDIATED CYTOTOXICITY TO LYSE HER2-POSITIVE CANCER CELLS

#245
20240052355
2024-02-15

APTAMER-siRNA FUSIONS

#246
20240052354
2024-02-15

COMPOSITIONS AND METHODS TO TREAT CANCER

#247
20240052353
2024-02-15

Bispecific Aptamer Compositions for the Treatment of Retinal Disorders

#248
20240036057
2024-02-01

DNA APTAMERS FOR THE DETECTION OF MONOMERIC CRP

#249
20240036039
2024-02-01

SHELF-STABLE, READY-TO-USE, ELECTROCHEMICAL APTAMER SENSORS

#250
20240035035
2024-02-01

COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING VIRAL INFECTIONS

#251
20240033361
2024-02-01

NEUTRALIZABLE COVALENT DRUG

#252
20240026366
2024-01-25

DUAL-SPECIFIC APTAMER TRIGGERING CELL-MEDIATED CYTOTOXICITY TO LYSE HER2-POSITIVE CANCER CELLS

#253
20240026334
2024-01-25

DNA-COLLAGEN COMPLEXES AND MAGNETOELECTRIC JANUS MATERIALS FOR BIOMEDICAL APPLICATIONS

#254
20240018526
2024-01-18

DEOXYRIBONUCLEIC ACID-BASED BIOSENSOR AND ASSOCIATED METHODS

#255
20240002878
2024-01-04

Universal platform to enhance CRISPR-based gene editing for in vivo therapies

#256
20240002862
2024-01-04

REGULATION OF GENE EXPRESSION BY APTAMER-MODULATED RNASE P CLEAVAGE

#257
20240002861
2024-01-04

COMPOSITIONS AND METHODS FOR TREATMENT OF BLEEDING DISORDERS

#258
20240002860
2024-01-04

SARS-CoV-2 SPIKE GLYCOPROTEIN-BINDING NUCLEIC ACID MOLECULE, SARS-CoV-2 DETECTION SENSOR, SARS-CoV-2 DETECTION REAGENT, SARS-CoV-2 DETECTION METHOD, AND SARS-CoV-2 VIRUS DEACTIVATOR

#259
20240002797
2024-01-04

METHODS OF CELL CULTURE FOR ADOPTIVE CELL THERAPY

#260
20230392169
2023-12-07

NUCLEIC ACID NANOSTRUCTURES FOR DELIVERY OF NUCLEIC ACID SEQUENCES TO CELLS

#261
20230392157
2023-12-07

APTAMER METHOD

#262
20230383250
2023-11-30

METHODS OF CELL CULTURE FOR ADOPTIVE CELL THERAPY

#263
20230382976
2023-11-30

APTAMER ASSEMBLIES FOR PROTEIN CROSSLINKING

#264
20230382964
2023-11-30

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#265
20230381322
2023-11-30

METHOD FOR PREPARING A DNA NETWORK WITH CONTROLLED CRYSTAL STRUCTURE AND A METHOD FOR INJECTING DRUGS USING THE DNA NETWORK

#266
20230374528
2023-11-23

COMPOSITIONS, SYSTEMS, AND METHODS FOR ORTHOGONAL GENOME ENGINEERING IN PLANTS

#267
20230374492
2023-11-23

PROCESS FOR SELECTION OF APTAMERS, RIBOSWITCHES AND DESOXYRIBOSWITCHES

#268
20230364123
2023-11-16

Methods for treating or preventing ophthalmological conditions

#269
20230364122
2023-11-16

METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS

#270
20230357790
2023-11-09

SELF-TARGETING EXPRESSION VECTOR

#271
20230348592
2023-11-02

METHODS FOR DE-CLOAKING CANCER FROM THE IMMUNE SYSTEM THROUGH DOWNREGULATION OF CANCER-PRODUCED PREGNANCY SPECIFIC GLYCOPROTEIN

#272
20230346837
2023-11-02

PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS

#273
20230340496
2023-10-26

APTAMER TEMPLATE AND METHOD FOR PREPARING APTAMER BY USING SAME

#274
20230340495
2023-10-26

APTAMERS FOR PERSONAL HEALTH CARE APPLICATIONS

#275
20230340451
2023-10-26

COMPOSITIONS COMPRISING LINEAR POLYRIBONUCLEOTIDES FOR PROTEIN MODULATION AND USES THEREOF

#276
20230340149
2023-10-26

METHODS OF TREATMENT OF INFLAMMATORY BOWEL DISEASES

#277
20230340046
2023-10-26

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#278
20230338489
2023-10-26

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

#279
20230333096
2023-10-19

APTAMER SENSORS WITH CONTINUOUS SOLUTE PASSIVATION

#280
20230332252
2023-10-19

CELL-FREE BIOSENSORS WITH DNA STRAND DISPLACEMENT CIRCUITS AND POLYMERASE STRAND RECYCLING (PSR)

#281
20230332161
2023-10-19

BUILDING DESIGNER RNA NANO-STRUCTURES FOR SYNTHETIC BIOLOGY APPLICATIONS

#282
20230332159
2023-10-19

MATERIALS AND METHODS FOR THE DELIVERY OF THERAPEUTIC NUCLEIC ACIDS TO TISSUES

#283
20230332145
2023-10-19

BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF

#284
20230331807
2023-10-19

IMMUNOTHERAPY WITH B*07 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS

#285
20230330277
2023-10-19

Radioisotope and Aptamer Drug Combination to treat S. aureus and E. coli infections

#286
20230330271
2023-10-19

THROMBUS IMAGING APTAMERS AND METHODS OF USING SAME

#287
20230324411
2023-10-12

Targeting ligands for tau pathology

#288
20230323487
2023-10-12

PORTABLE DETECTION OF SARS-COV-2 USING UNIMOLECULAR APTASENSORS

#289
20230313204
2023-10-05

ANTI-CHYMASE APTAMER AND USE FOR SAME

#290
20230313203
2023-10-05

FLUOROARABINO NUCLEIC ACID (FANA) APTAMERS THAT BIND SARS-2 RECEPTOR BINDING DOMAIN AND BLOCK BINDING TO THE ACE2 CELLULAR RECEPTOR

#291
20230313202
2023-10-05

Oligonucleotides comprising modified nucleosides

#292
20230313201
2023-10-05

APTAMERS FOR PERSONAL HEALTH CARE APPLICATIONS

#293
20230312679
2023-10-05

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS

#294
20230312520
2023-10-05

NUCLEIC ACID-BINDING PHOTOPROBES AND USES THEREOF

#295
20230304020
2023-09-28

LENTIVIRAL-FREE CYTOSOLIC DELIVERY OF PAYLOADS VIA APTAMERS

#296
20230304019
2023-09-28

DNA aptamer, pharmaceutical composition comprising same, method for inhibiting catalytic ability of TXNDC5, and method for preventing or treating organ fibrosis

#297
20230301552
2023-09-28

CONTINUOUS CORTISOL MONITORING SYSTEM WITH MICRONEEDLE ARRAY

#298
20230296619
2023-09-21

Method for Detecting Alpha Fetoprotein Glycoforms by High Resolution Intact Mass Analysis

#299
20230295636
2023-09-21

APTAMER BASED AFFINITY CAPTURE METHODS FOR THE SELECTIVE ENRICHMENT OF HUMAN IMMUNOGLOBULIN FC DOMAINS

#300
20230295635
2023-09-21

DNA APTAMERS FOR EOSINOPHIL PEROXIDASE DETECTION